Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops?

Medical therapy is the first-line option in glaucoma management, with benzalkonium chloride (BAC) being the most frequently used preservative in antiglaucoma medications. Its use is however, known to be associated with deleterious effects on the ocular surface. This review is an attempt to criticall...

Descripción completa

Detalles Bibliográficos
Autores principales: Louati, Y, Shaarawy, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2012
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741120/
https://www.ncbi.nlm.nih.gov/pubmed/26997764
http://dx.doi.org/10.5005/jp-journals-10008-1115
_version_ 1782413948513943552
author Louati, Y
Shaarawy, T
author_facet Louati, Y
Shaarawy, T
author_sort Louati, Y
collection PubMed
description Medical therapy is the first-line option in glaucoma management, with benzalkonium chloride (BAC) being the most frequently used preservative in antiglaucoma medications. Its use is however, known to be associated with deleterious effects on the ocular surface. This review is an attempt to critically evaluate whether BAC really is indispensable for better bioavailability of antiglaucoma drugs and consequently, better IOP control. How to cite this article: Louati Y, Shaarawy T. Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops? J Current Glau Prac 2012;6(3):104-107.
format Online
Article
Text
id pubmed-4741120
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-47411202016-03-18 Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops? Louati, Y Shaarawy, T J Curr Glaucoma Pract Perspective Medical therapy is the first-line option in glaucoma management, with benzalkonium chloride (BAC) being the most frequently used preservative in antiglaucoma medications. Its use is however, known to be associated with deleterious effects on the ocular surface. This review is an attempt to critically evaluate whether BAC really is indispensable for better bioavailability of antiglaucoma drugs and consequently, better IOP control. How to cite this article: Louati Y, Shaarawy T. Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops? J Current Glau Prac 2012;6(3):104-107. Jaypee Brothers Medical Publishers 2012 2012-10-16 /pmc/articles/PMC4741120/ /pubmed/26997764 http://dx.doi.org/10.5005/jp-journals-10008-1115 Text en Copyright © 2012; Jaypee Brothers Medical Publishers (P) Ltd. This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/
spellingShingle Perspective
Louati, Y
Shaarawy, T
Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops?
title Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops?
title_full Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops?
title_fullStr Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops?
title_full_unstemmed Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops?
title_short Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops?
title_sort controversy: is benzalkonium chloride necessary in antiglaucoma drops?
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741120/
https://www.ncbi.nlm.nih.gov/pubmed/26997764
http://dx.doi.org/10.5005/jp-journals-10008-1115
work_keys_str_mv AT louatiy controversyisbenzalkoniumchloridenecessaryinantiglaucomadrops
AT shaarawyt controversyisbenzalkoniumchloridenecessaryinantiglaucomadrops

Ejemplares similares